Clinical Trials Browser

Recurrence × apatinib × Gynecologic × Clear all

NCT04047017 2021-07-30

GTN

Phase 2 Completed

Recurrence, Gestational Trophoblastic Disease

NCT03298074 2017-09-29

Apatinib Plus Etoposide Versus Etoposide Alone for Platinum-resistant Recurrent Ovarian Cancer

Phase 2 Unknown

Ovarian Neoplasms, Recurrence